Anti-inflammatory effects of omega 3 and omega 6 polyunsaturated fatty acids in cardiovascular disease and metabolic syndrome

Critical Reviews in Food Science and Nutrition

Volumn 57, Issue 16, 2017, Pages 3421-3429

  Tortosa Caparrós, Esther ^a   Navas Carrillo, Diana ^b   Marín, Francisco ^a   Orenes Piñero, Esteban ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

cardiovascular disease; inflammation; obesity and type 2 Diabetes Mellitus; Omega 3 PUFA; omega 6 PUFA

Indexed keywords

BIOSYNTHESIS; CARDIOLOGY; DISEASES; HORMONES; INSULIN; METABOLISM; NUTRITION; PATHOLOGY; POLYUNSATURATED FATTY ACIDS; UNSATURATED FATTY ACIDS;

CARDIO-VASCULAR DISEASE; INFLAMMATION; OMEGA-3; OMEGA-6 PUFA; TYPE-2 DIABETES;

FATTY ACIDS;

ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

CARDIOVASCULAR DISEASE; HUMAN; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS;

ANTI-INFLAMMATORY AGENTS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS; METABOLIC SYNDROME;

EID: 85019901006     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2015.1126549     Document Type: Article

References (60)

1. Alberti, K. G., Zimmet, P., Shaw, J., and IDF Epidemiology Task Force Consensus Group. (2005). The metabolic syndrome-a new worldwide definition. Lancet 366:1059–1062.
2. Ambeba, E. J., Styn, M. A., Kuller, L. H., Brooks, M. M., Evans, R. W., and Burke, L. E., (2013). Longitudinal effects of weight loss and regain on cytokine concentration of obese adults. Metabolism. 62:1218–1222.
3. Bang, H.O., and Dyerberg, J., (1980). Lipid metabolism and ischemic heart disease in Greenland Eskimos. In:Advanced Nutrition Research, pp:1–32. Draper, H. H., Ed.,Plenum Press, New York, NY.
4. Block, R. C., Harris, W. S., Reid, K. J., Sands, S. A., and Spertus, J. A., (2008). EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis 197:821–828.
5. Bokarewa, M., Nagaev, I., Dahlberg, L., Smith, U., and Tarkowski, A., (2005). Resistin, an adipokine with potent proinflammatory properties. J.Immunol. 174:5789–5795.
6. Calder, P. C., (2007). Immunomodulation by omega-3 fatty acids. Prostaglandins LeukotEssent Fatty Acids. 77:327–335.
7. Burr, M. L., Fehily, A. M., Gilbert, J. F., Rogers, S., Holliday, R. M., Sweetnam, P. M., Elwood, P. C., and Deadman, N. M., (1989). Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction:Diet and Reinfarction Trial (DART). Lancet. 2:757–761.
8. Calò, L., Bianconi, L., Colivicchi, F., Lamberti, F., Loricchio, M. L., de Ruvo, E., Meo, A., Pandozi, C., Staibano, M., and Santini, M., (2005). n-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery:a randomized, controlled trial. J. Am. Coll.Cardiol. 45:1723–1728.
9. Calder, P. C., (2008).The relationship between the fatty acid composition of immune cells and their function. Prostaglandins LeukotEssent Fatty Acids 79:101–108.
10. Choi, H. Y., Kim, S., Yang, S. J., Yoo, H. J., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., Choi, D. S., and Choi, K. M., (2011). Association of adiponectin, resistin, and vascular inflammation:Analysis with 18F-fluorodeoxyglucose positron emission tomography. ArteriosclerThromb.Vasc. Biol. 31:944–949.
11. Darghosian, L., Free, M., Li, J., Gebretsadik, T., Bian, A., Shintani, A., McBride, B. F., Solus, J., Milne, G., Crossley, G. H., Thompson, D., Vidaillet, H., Okafor, H., Darbar, D., Murray, K. T., and Stein, C. M., (2015). Effect of omega-three polyunsaturated fatty acids on inflammation, oxidative stress, and recurrence of atrial fibrillation. Am. J.Cardiol. 115:196–201.
12. Dawson, D. R., 3rd., Branch-Mays, G., Gonzalez, O. A., and Ebersole, J. L., (2014). Dietary modulation of the inflammatory cascade. Periodontology. 2000(64):161–197.
13. Després, J. P., (2012). Abdominal obesity and cardiovascular disease:Is inflammation the missing link? Can. J. Cardiol. 28:642–652.
14. Duan, Y., Li, F., Li, L., Fan, J., Sun, X., and Yin, Y., (2014). n-6:n-3 PUFA ratio is involved in regulating lipid metabolism and inflammation in pigs. Br. J. Nutr. 111:445–451.
15. Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M. I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., Lamuela-Raventos, R. M., Serra-Majem, L., Pintó, X., Basora, J., Muñoz, M. A.,Sorlí, J. V., Martínez, J. A., Martínez-González, M. A., and PREDIMED Study Investigators. (2013). Primary prevention of cardiovascular disease with a Mediterranean diet. N. Engl. J. Med. 368:1279–1290.
16. Fodor, J. G., Helis, E., Yazdekhasti, N., and Vohnout, B., (2014). “Fishing” for the origins of the “Eskimos and heart disease” story:Facts or wishful thinking? Can. J.Cardiol. 30:864–868.
17. Grundy, S. M., Brewer, H. B., Jr., Cleeman, J. I., Smith, S. C., Jr. and Lenfant, C., (2004). Definition of metabolic syndrome:Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 109:433–438.
18. GruppoItaliano per lo Studio dellaSopravvivenzanell'Infartomiocardico. (1999). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction:results of the GISSI-Prevenzione trial. Lancet. 354:447–455.
19. Haluzik, M., Parizkova, J., and Haluzik, M. M., (2004). Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol.Res. 53:123–129.
20. Heinonen, M. V., Laaksonen, D. E., Karhu, T., Karhunen, L., Laitinen, T., Kainulainen, S., Rissanen, A., Niskanen, L., and Herzig, K. H., (2009). Effect of diet-induced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome. Nutr.Metab.Cardiovasc.Dis. 19:626–633.
21. Hernández-Romero, D., Jover, E., Marín, F., Vilchez, J. A., Manzano-Fernandez, S., Romera, M., Vicente, V., Valdés, M., Lip, G. Y., and Roldán, V., (2013). The prognostic role of the adiponectin levels in atrial fibrillation. Eur. J.Clin.Invest. 43:168–173.
22. Hu, F. B., Bronner, L., Willett, W. C., Stampfer, M. J., Rexrode, K. M., Albert, C. M., Hunter, D., and Manson, J. E., (2002). Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA. 287:1815–1821.
23. Iso, H., Kobayashi, M., Ishihara, J., Sasaki, S., Okada, K., Kita, Y., Kokubo, Y., Tsugane, S., and JPHC Study Group. (2006). Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese:The Japan Public Health Center-based (JPHC) study cohort I. Circulation. 113:195–202.
24. Klöting, N., and Blüher, M., (2014). Adipocyte dysfunction, inflammation and metabolic syndrome. Rev.Endocr.Metab.Disord. 15:277–287.
25. Kondo, K., Morino, K., Nishio, Y., Kondo, M., Fuke, T., Ugi, S., Iwakawa, H., Kashiwagi, A., and Maegawa, H., (2010). Effects of a fish-based diet on the serum adiponectin concentration in young, non-obese, healthy Japanese subjects. J.Atheroscler.Thromb. 17:628–637.
26. La Cava, A., and Matarese, G., (2004). The weight of leptin in immunity. Nat. Rev.Immunol. 4:371–379.
27. Lau, D. C., Dhillon, B., Yan, H., Szmitko, P. E., and Verma, S., (2005). Adipokines:Molecular links between obesity and atheroslcerosis. Am. J. Physiol. Heart Circ.Physiol. 288:H2031–H2041.
28. Liu, M. J., Bao, S., Napolitano, J. R., Burris, D. L., Yu, L., Tridandapani, S., and Knoell, D. L., (2014). Zinc regulates the acute phase response and serum amyloid A production in response to sepsis through JAK-STAT3 signaling. PLoSOne 9:1–15.
29. Liu, P., Li, C., Huang, J., and Ji, H., (2014). Regulation of adipocytes lipolysis by n-3 HUFA in grass carp (Ctenopharyngodonidellus) in vitro and in vivo. Fish Physiol.Biochem. 40:1447–1460.
30. Locksley, R. M., Killeen, N., and Lenardo, M. J., (2001). The TNF and TNF receptor superfamilies:Integrating mammalian biology. Cell 104:487–501.
31. Lovren, F., Teoh, H., and Verma, S., (2015). Obesity and Atherosclerosis:Mechanistic Insights. Can. J.Cardiol. 31:177–183.
32. Maury, E., and Brichard, S. M., (2010). Adipokinedysregulation, adipose tissue inflammation and metabolic syndrome. Mol. Cell Endocrinol. 314:1–16.
33. Mizia-Stec, K., Haberka, M., Mizia, M., Chmiel, A., Gieszczyk, K., Lasota, B., Janowska, J., Zahorska-Markiewicz, B., and Gąsior, Z., (2011). N-3 Polyunsaturated fatty acid therapy improves endothelial function and affects adiponectin and resistin balance in the first month after myocardial infarction. Arch. Med.Sci. 7:788–795.
34. Moreno-Aliaga, M. J., Lorente-Cebrián, S., and Martinez, J. A., (2010). Regulation of adipokine secretion by n-3 fatty acids. Proc. Nutr. Soc. 69:324–332.
35. Mostowik, M., Gajos, G., Zalewski, J., Nessler, J., and Undas, A., (2013). Omega-3 polyunsaturated fatty acids increase plasma adiponectin to leptin ratio in stable coronary artery disease. Cardiovasc.Drugs Ther. 27:289–295.
36. Mozaffarian, D., Marchioli, R., Macchia, A., Silletta, M. G., Ferrazzi, P., Gardner, T. J., Latini, R., Libby, P., Lombardi, F., O'Gara, P. T., Page, R. L., Tavazzi, L., Tognoni, G., and OPERA Investigators. (2012). Fish oil and postoperative atrial fibrillation:the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial. JAMA 308:2001–2011.
37. Mullen, A., Loscher, C. E., and Roche, H. M., (2010). Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages. J. Nutr. Biochem. 21:444–450.
38. Murray, E. T., Hardy, R., Hughes, A., Wills, A., Sattar, N., Deanfield, J., Kuh, D., and Whincup, P., (2015). Overweight across the life course and adipokines, inflammatory and endothelial markers at age 60–64 years:Evidence from the 1946 birth cohort. Int. J.Obes.(Lond). 39:1010–1018.
39. Nigam, A., Talajic, M., Roy, D., Nattel, S., Lambert, J., Nozza, A., Jones, P., Ramprasath, V. R., O'Hara, G., Kopecky, S., Brophy, J. M., Tardif, J. C., and AFFORD Investigators. (2014). Fish oil for the reduction of atrial fibrillation recurrence, inflammation, and oxidative stress. J. Am. Coll.Cardiol. 64:1441–1448.
40. Ntaios, G., Gatselis, N. K., Makaritsis, K., and Dalekos, G. N., (2013). Adipokines as mediators of endothelial function and atherosclerosis. Atherosclerosis 227:216–221.
41. Okui, H., Hamasaki, S., Ishida, S., Kataoka, T., Orihara, K., Fukudome, T., Ogawa, M., Oketani, N., Saihara, K., Shinsato, T., Shirasawa, T., Mizoguchi, E., Kubozono, T., Ichiki, H., Ninomiya, Y., Matsushita. T., Nakasaki, M., and Tei, C., (2008). Adiponectin is a better predictor of endothelial function of the coronary artery than HOMA-R, body mass index, immunoreactive insulin, or triglycerides. Int. J.Cardiol. 126:53–61.
42. Peyron-Caso, E., Taverna, M., Guerre-Millo, M., Véronèse, A., Pacher, N., Slama, G., and Rizkalla, S. W., (2002). Dietary (n-3) polyunsaturated fatty acids up-regulate plasma leptin in insulin-resistant rats. J. Nutr. 132:2235–2240.
43. Rasmussen-Torvik, L. J., Pankow, J. S., Jacobs, D. R., Jr., Steinberger, J., Moran, A., and Sinaiko, A.R., (2012). Development of associations among central adiposity, adiponectin and insulin sensitivity from adolescence to young adulthood. Diabet. Med. 29:1153–1158.
44. Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., and Cook, N. R., (2002). Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J.Med. 347:1557–1565.
45. Ridker, P. M., Wilson, P. W., and Grundy, S. M., (2004). Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 109:2818–2825.
46. Rix, T. A., Joensen, A. M., Riahi, S., Lundbye-Christensen, S., Tjønneland, A., Schmidt, E. B., and Overvad, K., (2014). A U-shaped association between consumption of marine n-3 fatty acids and development of atrial fibrillation/atrial flutter-a Danish cohort study. Europace 16:1554–1561.
47. Rodrigo, R., Korantzopoulos, P., Cereceda, M., Asenjo, R., Zamorano, J., Villalabeitia, E., Baeza, C., Aguayo, R., Castillo, R., Carrasco, R., and Gormaz, J. G., (2013). A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement. J. Am. Coll.Cardiol. 62:1457–1465.
48. Romacho, T., Glosse, P., Richter, I., Elsen, M., Schoemaker, M. H., van Tol, E. A., and Eckel, J., (2015). Nutritional ingredients modulate adipokine secretion and inflammation in human primary adipocytes. Nutrients 7:865–886.
49. Sáinz, N., Barrenetxe, J., Moreno-Aliaga, M. J., and Martínez, J. A., (2015). Leptin resistance and diet-induced obesity:Central and peripheral actions of leptin. Metabolism. 64:35–46.
50. Savelieva, I., Kourliouros, A., and Camm, J., (2010). Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids:Review of evidence and clinical relevance. Naunyn. Schmiedebergs Arch. Pharmacol. 381:1–13.
51. Simopoulos, A. P., (2008). The importance of the omega-6/omega- 3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med. (Maywood). 233:674–688.
52. Singh, M., Kommu, S., Sethi, A., and Arora, R., (2013). Omega-3 fatty acids in prevention of post-cardiac surgery atrial fibrillation:A meta-analysis of randomized controlled trials. J. Am. Coll.Cardiol. 61:(Suppl):E1455.
53. Siriwardhana, N., Kalupahana, N. S., Fletcher, S., Xin, W., Claycombe, K. J., Quignard-Boulange, A., Zhao, L., Saxton, A. M., and Moustaid-Moussa, N., (2012). n-3 and n-6 polyunsaturated fatty acids differentially regulate adipose angiotensinogen and other inflammatory adipokines in part via NF-κB-dependent mechanisms. J.Nutr.Biochem. 23:1661–1667.
54. Siscovick, D. S., Raghunathan, T. E., King, I., Weinmann, S., Wicklund, K. G., Albright, J., Bovbjerg, V., Arbogast, P., Smith, H., and Kushi, L. H., (1995). Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274:1363–1367.
55. Steppan, C. M., and Lazar, M. A., (2004). The current biology of resistin. J. Intern.Med. 255:439–447.
56. Trayhurn, P., Bing, C., and Wood, I. S., (2006). Adipose tissue and adipokines–energy regulation from the human perspective. J.Nutr. 136:1935S–1939S.
57. Tripathi, Y. B., and Pandey, V., (2012). Obesity and endoplasmic reticulum (ER) stresses. Front.Immunol. 3:240.
58. Virtanen, J. K., Mursu, J., Voutilainen, S., and Tuomainen, T. P., (2009). Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men. Circulation 120:2315–2321.
59. Wilbring, M., Ploetze, K., Bormann, S., Waldow, T., and Matschke, K., (2014). Omega-3 polyunsaturated Fatty acids reduce the incidence of postoperative atrial fibrillation in patients with history of prior myocardial infarction undergoing isolated coronary artery bypass grafting. ThoracCardiovasc. Surg. 62:569–574.
60. Wolk, R., Berger, P., Lennon, R. J., Brilakis, E. S., Johnson, B. D., and Somers, V. K., (2004). Plasma leptin and prognosis in patients with established coronary atherosclerosis. J. Am. Coll.Cardiol. 44:1819–1824.